Cite
MLA Citation
Martina Lorenzi et al.. “First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.” Oncologist, vol. 27, 2022, pp. 87–e115. http://access.bl.uk/ark:/81055/vdc_100151267146.0x00001b